determine the in vivo roles of IL-9, we have assessed
Antigen-Specific Cytokine and Antibody Responses Are Normal in IL-9-Deficient Mice the immune responses of the IL-9-deficient animals to
We also assessed whether the absence of IL-9 would a range of immunological challenges that normally proalter the induction of antigen-specific systemic immune voke a Th2 phenotype.
responses following immunization with antigen. IL-9-deficient and wild-type mice were challenged with ovalbumin complexed with the adjuvant alum and their cytokine Naive Cytokine Levels, Th1 and Th2 Cell Development, and immunoglobulin responses analyzed. Mesenteric and Total Serum Immunoglobulin Production lymph node cells from the immunized mice were restimAre Normal in IL-9-Deficient Mice ulated in vitro using either anti-CD3 or antigen and their Since in vitro assays have demonstrated a role for IL-9 cytokine production determined. Polyclonal and antiin T cell activation, we wished to address whether the gen-driven cytokine responses from immunized IL-9-disruption of IL-9 expression in vivo would alter the deficient mice were comparable to those produced by levels of T cell cytokine production. Polyclonal stimulathe wild-type control animals ( Figure 3A) . Similarly, antition of mesenteric lymph node cells from naive animals gen-specific immunoglobulin responses were also unalwith anti-CD3 demonstrated that IL-5, IL-10, and IFN-␥ tered by the absence of IL-9 expression ( Figure 3B ). production was not altered by the absence of IL-9 (FigThus, despite reports that IL-9 can alter the in vitro ure 2A). Similarly, when lymph node cells were cultured differentiation of B cells and enhance total immunoglobin vitro under conditions that promote differentiation of ulin expression, we have been unable to demonstrate Th1 or Th2 cells, no significant differences were oba significant role for IL-9 in this process in vivo following served in the generation of these lineages in the IL-9-IL-9 gene disruption. Our data indicate that in the abdeficient or wild-type mice ( Figure 2B ). In keeping with sence of IL-9 compensatory pathways exist for the northe unaltered expression of cytokines, the total serum mal development of immunoglobulin responses. immunoglobulin isotype responses detected in the IL-9-deficient mice were comparable to those in the wildtype controls ( Figure 2C) . Furthermore, FACS analysis Goblet Cell Hyperplasia and Mastocytosis Is of cell suspensions prepared from lymph node, spleen, Severely Impaired in IL-9-Deficient Animals bone marrow, peritoneum, and thymus, from naive ILfollowing the Induction of Synchronous 9-deficient and wild-type mice, demonstrated no differPulmonary Granuloma Formation ences in the expression of the following cell surface To determine the in vivo contribution of IL-9 in a Th2 markers: CD4, CD8, T cell receptor, CD3, CD5, CD25, cytokine-mediated inflammatory response, we em-CD45, Gr-1 on thymocytes; CD4, CD8, T cell receptor, ployed a model system in which synchronous pulmonary CD3, CD5, CD14, CD23, CD45, Gr-1, CD11b, TER119 granuloma formation is induced around Schistosoma on mesenteric lymph node cells or splenocytes; CD3, mansoni eggs (Warren and Domingo, 1970) . In this CD5, CD14, CD23, CD24, CD43, CD45, Gr-1, CD11b, model, a cellular granulomatous response develops TER119, BP1, c-kit on bone marrow; CD5, CD45, CD11b, around parasite eggs that lodge in the lungs following their intravenous injection into mice. This inflammatory c-kit, Gr-1 on peritoneal lavage (data not shown). To determine whether the differences observed in the goblet cell hyperplasia were simply due to a decrease in pulmonary inflammation, we analyzed the composition of the granulomas and lung tissue. We observed that both the IL-9-deficient and wild-type animals developed granulomas of equivalent size and cellularity ( Figures  5A and 5B), with eosinophils constituting ‫%03ف‬ of the granuloma ( Figure 5C ). Furthermore, analysis of lung tissue and bronchoalveolar lavage (BAL) showed no difference in the inflammatory response. Pulmonary fibrosis as assessed by collagen deposition was equivalent in the two mouse lines ( Figure 5D ), as were the proportions of eosinophils, neutrophils, macrophages, and lymphocytes in the BAL fluid ( Figure 5E ). In addition, we also analyzed the levels of the cellular adhesion molecules ICAM-1 (CD54) and VCAM-1 (CD106), which are normally associated with inflammatory processes (Bevilacqua, 1993). Histological examination of lung tissue from immunized IL-9-deficient and wild-type animals demonstrated equivalent staining for ICAM-1 and VCAM-1 ( Figure 5F ) as determined using the arbitrary scoring system outlined in Experimental Procedures. Since IL-4, IL-5, and IL-13 have been shown to play important roles in the development of pulmonary Th2 responses, we assessed the expression of these cytokines from cultures prepared from the draining mediastinal lymph nodes of wild-type and IL-9-deficient mice following primary immunization. Significantly, we found equivalent antigen-induced expression of IL-4, IL-5, and IL-13 by the wild-type and IL-9-deficient mice ( Figure 5G ). Thus, the observed reduction in goblet cell and mast cell numbers in the IL-9-deficient mice occurs independently of these cytokines, indicating that IL-9 is a key regulator of these processes. Moreover, these data also indicate that the induction of IL-4, IL-5, and IL-13 is not regulated by IL-9.
Previous studies using cytokine-deficient mice have demonstrated that IL-4 and IL-5 do not play an essential role in Th2 cell driven pulmonary mucus production Figure 6E ). Thus, both IL-9 and IL-13 can regulate goblet cell hyperplasia. Critically, since in the IL-9-deficient mice IL-13 was expressed normally but could not compensate for the lack of IL-9 in the primary response, this highlights an important primary role for IL-9 in the initiation of the goblet cell response. Thus, the primary pulmonary granulomatous model demonstrates that although mice deficient in IL-9 are still capable of mounting an eosinophil-rich Th2-mediated inflammatory response, they fail to generate the normal goblet cell hyperplasia and mastocytosis associated with primary lung challenge. It is noteworthy that following secondary challenge the pulmonary granulomatous response produces an equivalent induction of goblet and mast cells even in the absence of IL-9 expression (data not shown). These data demonstrate that the role of IL-9 in this response is an early event and that further compensatory factors can modulate the goblet cell response following priming. In order to investigate the in vivo roles of IL-9, we have generated a novel line of IL-9-deficient mice. The imdeficient mice (n ϭ 4) had 2.94 Ϯ 0.52 mast cells per villus crypt (p Ͻ 0.11 by Student's t-test). Previously, it mune functions of these animals have been evaluated both in naive mice and in animals following immunization has been shown that mice overexpressing IL-9 have marked mast cell infiltration of the muscularis mucosa or infection. These studies have highlighted an important role for IL-9 in the rapid and robust generation of (Godfraind et al., 1998). To more accurately determine the full extent of intestinal mastocytosis in nematodepulmonary goblet cell hyperplasia and mastocytosis. However, our studies have failed to show a significant infected mice, we measured the levels of mast cell proteases (mMCP-1) in homogenates of jejunum from inrole for IL-9 in T cell development or differentiation, the generation of naive or antigen-driven antibody refected mice. Throughout the course of infection with N. brasiliensis, mMCP-1 activity in the jejunum was lower sponses, or the expulsion of the intestinal parasitic nematode N. brasiliensis. in IL-9 deficient mice compared to wild type mice ( Figure  7C ). It is appropriate to highlight that in separate nemaDespite reports that IL-9 can act as a growth factor for certain T cell clones (Van Snick et al., 1989) and tode infection studies, although we have consistently observed reduced intestinal mastocytosis in IL-9 defithe observed development of thymic lymphomas in IL-9 transgenic mice (Renauld et al., 1994), we were unable cient mice, based on two different mast cell histological stains and detection of mast cell protease activity, these to identify changes in the T cell subpopulations of the thymus or peripheral lymphoid tissues from the IL-9-differences have not been statistically significant. Antigen-specific antibody responses following infection deficient mice. Thus, if IL-9 does play a role in T cell development, alternative pathways must function in its were also comparable between the two groups (data not shown). Polyclonal and antigen-specific cytokine absence. This represents an important finding, since IL-9 binds to a receptor complex that includes the IL-9R production from the mesenteric lymph node cells of the IL-9-deficient and wild-type mice indicate comparable and ␥ c , and it has been suggested that IL-9 may represent an additional signal that is missing in human pacytokine responses at day 5 p.i. (Figure 7D ) but suggest that by day 10 p.i. the IL-9-deficient mice are making tients suffering from X-SCID, which is caused by muta- Using the pulmonary granuloma model, we have been able to study the onset of Th2 responses during both IL-2, IL-4, IL-7, and IL-15.
Responses to the
We have also found that immunoglobulin responses primary and secondary challenges in order to identify obligate roles for IL-9 in these immune responses. This are unaltered by the absence of IL-9. These data differ from those reported for the IL-9 transgenic mice that approach has proved highly illuminating, identifying that IL-9 is critically important for the rapid onset of goblet display a global increase in all immunoglobulin isotypes (Vink et al., 1999) . While it is not clear why this should cell hyperplasia and the upregulation of mast cells but not for eosinophilia, fibrosis, or lymphocyte function. be the case, it seems likely that aberrant overexpression of IL-9 induces indirect upregulation of B cell function, Th2 cell-mediated mucus production represents an important response for protecting mucosal surfaces. Alwhich does not represent a critical role for IL-9. To date, we have also failed to demonstrate any change in the though mucus production acts positively in the protection of mucosal surfaces from pathogens and by asnumber of peritoneal B-1 cells in the IL-9-deficient mice. These data also contrast with the findings from IL-9 sisting in parasite expulsion (Nawa et al., 1994) , it may also be detrimental by contributing to airway obstruction transgenic mice that display an expansion of a B-1 lymphocyte population that is independent of IL-5 reguladuring pulmonary inflammatory responses (Rogers, 1994) . The regulation of goblet cell mucus production by cytotion (Vink et al., 1999) . Our data from IL-9-deficient production but apparently enhances mast cell expanmice now demonstrate that IL-9 is a critical factor for sion in the lung tissue. These data contrast with those initiating the primary goblet cell response following prireported for IL-3-deficient mice in which impaired mast mary pulmonary challenge. Significantly, this regulation cell outgrowth results from a defect in mast cell progeniof goblet cell hyperplasia is independent of IL-13, IL-4, tor development (Lantz et al., 1998). Interestingly, we and IL-5. Moreover, IL-9-deficient mice developed othalso observed that prolonged in vivo exposure to antierwise normal pulmonary Th2 inflammatory responses gen, in the form of a secondary immunization, overrides with characteristic eosinophilia, ICAM-1 and VCAM-1 the dependence on IL-9, and other factors can then expression, fibrosis, and BAL cell composition, indicatcompensate for the role of IL-9 in mastocytosis. Cering that the goblet cell defect is not due to a diminution tainly stem cell factor, IL-3, and IL-4 are all capable of of the inflammatory response but is specific to the deficit inducing mast cell outgrowth (Galli and Hammel, 1994). in IL-9 expression.
Despite our observations in the lung demonstrating There is obvious complexity to the interrelated roles of that IL-9 plays a significant role in modulating the im-IL-9 and IL-13 in the regulation of goblet cell production. mune response to antigen, we have been unable to Clearly, IL-13 expression in the primary challenge is nordetermine an essential role for IL-9 in the expulsion of mal yet fails to compensate for the absence of IL-9. the parasitic nematode worm N. brasiliensis. Although Therefore, IL-9 must act independently of IL-13 in initiatwe observed fewer goblet cells in the IL-9-deficient ing this response. However, it is apparent that IL-13 is mice, parasite expulsion was not delayed by the abalso an important factor in the regulation of goblet cell sence of IL-9. However, we did observe an increase in responses. It is possible that IL-13 may perform a role IL-4 and IL-5 production by restimulated cells from the as a goblet cell-enhancing factor acting independently mesenteric lymph node of IL-9-deficient mice. This may of IL-9 and with slower kinetics or that it is necessary indicate that the disruption of IL-9 expression alters for developing the Th2 response and increasing IL-9 the balance of the normal response necessitating an expression. Our experiments using IL-13-deficient mice increase in the expression of other Th2 cytokines, which indicate that in the absence of IL-13, goblet cell hyperthen compensate for the loss of IL-9. Although studies plasia is also impaired though to a lesser degree than in have shown that IL-9 transgenic mice expel nematode the IL-9-deficient mice. In contrast to the IL-9-deficient parasite infections more efficiently than wild-type animice, the IL-13-deficient mice also develop a global mals, the physiological significance of these findings downregulation of the Th2 response with smaller granuis unclear since naive IL-9 transgenic mice display a lomas, a reduction in eosinophilia and fibrosis, and reseverely altered immune system. However, it is possible duced levels of IL-4, IL-5, and IL-9. The normal levels that analysis of other parasitic worm models, which vary of goblet cells induced following secondary challenge in their modes of colonisation, may uncover a mechaof the IL-9-deficient mice indicate that alternative IL-9-nism that is hidden in the N. brasiliensis model. independent mechanisms can compensate for the abIn conclusion, our data have highlighted an important sence of IL-9 following sensitization. Future studies will role for IL-9 in the rapid onset of goblet cell hyperplasia address the interrelated role of IL-13 in this process. and mastocytosis in a pulmonary Th2 response. These Our results demonstrating a key role for IL-9 in mucus results may have important consequences in the fields production are supported by a study of allergen-chalof asthma and allergy, and these mice should prove an lenged dogs in which IL-9, but not IL-5 or IL-13, was important resource for the evaluation of IL-9 function in found to be the only cytokine that correlated with mucus models of airway hyperresponsiveness. The transient production. 
